DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Clinical trials for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New TB drug combo enters phase 2 trial – hope for shorter treatment?
Disease control Recruiting nowThis study tests whether adding a new drug called TBD09 to standard TB medicines is safe and works better at killing TB bacteria. About 150 adults with drug-sensitive pulmonary TB will take part. The goal is to see if the combination can clear the infection faster and with fewer …
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 16, 2026 03:48 UTC
-
Could a vitamin boost TB treatment? new trial underway
Disease control Recruiting nowThis study tests whether adding nicotinamide (a form of vitamin B3) to a standard three-drug regimen can safely and effectively treat drug-susceptible tuberculosis (TB) in adults. About 165 participants with newly diagnosed, drug-sensitive TB will receive the combination or stand…
Matched conditions: DRUG SUSCEPTIBLE PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC